Legend Biotech Corporation

NasdaqGS:LEGN Stock Report

Market Cap: US$9.2b

Legend Biotech Management

Management criteria checks 2/4

Legend Biotech's CEO is Ying Huang, appointed in Sep 2020, has a tenure of 4.08 years. directly owns 0.035% of the company’s shares, worth $3.21M. The average tenure of the management team and the board of directors is 2.4 years and 3.3 years respectively.

Key information

Ying Huang

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.1yrs
CEO ownership0.03%
Management average tenure2.4yrs
Board average tenure3.3yrs

Recent management updates

Recent updates

Legend Biotech: Entering Accelerated Growth Phase, Carvykti Positions Company For Valuation Expansion

Sep 18

Optimistic Investors Push Legend Biotech Corporation (NASDAQ:LEGN) Shares Up 26% But Growth Is Lacking

Aug 01
Optimistic Investors Push Legend Biotech Corporation (NASDAQ:LEGN) Shares Up 26% But Growth Is Lacking

Legend Biotech's Promising CAR-T Therapies Face Valuation And Cash Burn Challenges

Jul 30

Rock star Growth Puts Legend Biotech (NASDAQ:LEGN) In A Position To Use Debt

Jul 05
Rock star Growth Puts Legend Biotech (NASDAQ:LEGN) In A Position To Use Debt

Legend Biotech's Carvykti Faces Stiff Challenges Despite Advances

May 14

Some Shareholders Feeling Restless Over Legend Biotech Corporation's (NASDAQ:LEGN) P/S Ratio

May 13
Some Shareholders Feeling Restless Over Legend Biotech Corporation's (NASDAQ:LEGN) P/S Ratio

Legend Biotech: AdCom Documents Shed Light On Carvykti's Problems (Downgrade)

Mar 15

Is Legend Biotech (NASDAQ:LEGN) A Risky Investment?

Mar 06
Is Legend Biotech (NASDAQ:LEGN) A Risky Investment?

Legend Biotech: Solid Traction With Carvykti Rollout

Jan 29

Legend Biotech Corporation's (NASDAQ:LEGN) Share Price Not Quite Adding Up

Jan 16
Legend Biotech Corporation's (NASDAQ:LEGN) Share Price Not Quite Adding Up

Is Legend Biotech (NASDAQ:LEGN) A Risky Investment?

Nov 09
Is Legend Biotech (NASDAQ:LEGN) A Risky Investment?

Is Legend Biotech (NASDAQ:LEGN) Weighed On By Its Debt Load?

Apr 12
Is Legend Biotech (NASDAQ:LEGN) Weighed On By Its Debt Load?

An Intrinsic Calculation For Legend Biotech Corporation (NASDAQ:LEGN) Suggests It's 44% Undervalued

Dec 14
An Intrinsic Calculation For Legend Biotech Corporation (NASDAQ:LEGN) Suggests It's 44% Undervalued

Legend Biotech wins approval of Carvykti for multiple myeloma in Japan

Sep 27

Legend Biotech stock slides on proposed ADS offering

Jul 25

Legend Biotech ends Phase 1 trial for lymphoma candidate

Jul 07

News Flash: Analysts Just Made A Notable Upgrade To Their Legend Biotech Corporation (NASDAQ:LEGN) Forecasts

Jun 05
News Flash: Analysts Just Made A Notable Upgrade To Their Legend Biotech Corporation (NASDAQ:LEGN) Forecasts

Legend Biotech (NASDAQ:LEGN) Has Debt But No Earnings; Should You Worry?

May 14
Legend Biotech (NASDAQ:LEGN) Has Debt But No Earnings; Should You Worry?

Here's What Analysts Are Forecasting For Legend Biotech Corporation (NASDAQ:LEGN) After Its Full-Year Results

Mar 22
Here's What Analysts Are Forecasting For Legend Biotech Corporation (NASDAQ:LEGN) After Its Full-Year Results

Legend Biotech: Carvykti Approval Makes For A Buy Opportunity

Mar 04

Legend Biotech Corporation (NASDAQ:LEGN) Analysts Are More Bearish Than They Used To Be

Mar 03
Legend Biotech Corporation (NASDAQ:LEGN) Analysts Are More Bearish Than They Used To Be

Is Legend Biotech (NASDAQ:LEGN) Weighed On By Its Debt Load?

Dec 30
Is Legend Biotech (NASDAQ:LEGN) Weighed On By Its Debt Load?

CEO

Ying Huang (51 yo)

4.1yrs

Tenure

Dr. Ying Huang, Ph D., had been Chief Financial Officer of Legend Biotech Corporation since July 2019 until May 09, 2022 and was its Interim Chief Executive Officer since September 21, 2020 until November...


Leadership Team

NamePositionTenureCompensationOwnership
Ying Huang
CEO & Director4.1yrsno data0.035%
$ 3.2m
Lori Macomber
Chief Financial Officer2.4yrsno data0.0031%
$ 281.0k
Doug Wallace
Vice President of Global Operationsless than a yearno datano data
Guowei Fang
Chief Scientific Officer & Head of Business Developmentno datano datano data
Joanne Choi
Senior Manager of Investor Relationsno datano datano data
James Pepin
General Counselless than a yearno datano data
Tim Roberts
Global Compliance Officerless than a yearno datano data
Deborah Wong
Executive Director of Strategic Marketing & Corporate Communicationsno datano datano data
Elaine Qian
VP & Global Head of Human Resources1.5yrsno datano data
Yuhong Qiu
Senior Vice President of Global Regulatory Affairs2.8yrsno datano data
Steven Gavel
Senior Vice President of Commercial Development2.8yrsno datano data
Alan Kick
Senior Vice President of Global Quality2.8yrsno datano data

2.4yrs

Average Tenure

Experienced Management: LEGN's management team is considered experienced (2.4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Ying Huang
CEO & Director2.8yrsno data0.035%
$ 3.2m
John M. Maraganore
Member of Strategic Advisory Board1.5yrsno datano data
Li Zhu
Non-Independent Director3.9yrsno datano data
Corazon Sanders
Independent Director4.4yrsno data0.010%
$ 960.1k
Xiaohui Ji
Independent Director4.4yrsno data0.0050%
$ 460.7k
Tomas Heyman
Independent Director2.2yrsno data0.0011%
$ 101.4k
Fangliang Zhang
Independent Chairman2.2yrsno data0%
$ 0
Ye Wang
Director9.4yrsno data0%
$ 0
Michel Vounatsos
Member of Strategic Advisory Board1.5yrsno datano data
Wai Man Yau
Independent Director4.4yrsno data0.0010%
$ 94.0k
Patrick Casey
Independent Director3.8yrsno data0.0069%
$ 633.0k
Li Mao
Independent Director2.2yrsno data0.0019%
$ 173.2k

3.3yrs

Average Tenure

62yo

Average Age

Experienced Board: LEGN's board of directors are considered experienced (3.3 years average tenure).